NNNN · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $1.3B · 27 employees
6
SEC Filings
$9.45
Close 2026-07-22
27
Employees
Business Summary
Anbio Biotechnology is a Cayman Islands-incorporated company that designs and sells in vitro diagnostic (IVD) products through its operating subsidiaries. Its product portfolio includes chemiluminescence immunoassay (ChLIA), fluorescence immunoassay (FIA), lateral flow immunoassay (LFIA), and molecular diagnostic tests. The company works with third-party laboratories for R&D and third-party manufacturers for production, and sells globally with CE-marked products while pursuing regulatory clearances in regional markets including the United States.
Look up NNNN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on NNNN, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/NNNN (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.